| Original language | English |
|---|---|
| Pages (from-to) | 1589-1596 |
| Number of pages | 8 |
| Journal | Haematologica |
| Volume | 104 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2019 |
Keywords
- alpha interferon
- bosutinib
- dasatinib
- imatinib
- nilotinib
- ponatinib
- protein tyrosine kinase inhibitor
- adult
- Article
- cancer chemotherapy
- cancer patient
- chronic myeloid leukemia
- chronopharmacology
- clinical practice
- drug intoxication
- drug safety
- drug withdrawal
- feasibility study
- female
- follow up
- human
- Italian (citizen)
- leukemia relapse
- leukemia remission
- major clinical study
- male
- observational study
- oncologist
- pregnancy
- retreatment
- retrospective study
- shared decision making
- treatment duration
- treatment failure
- treatment response
- treatment withdrawal
Cite this
Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice. / Fava, C.; Rege-Cambrin, G.; Dogliotti, I.; Cerrano, M.; Berchialla, P.; Dragani, M.; Rosti, G.; Castagnetti, F.; Gugliotta, G.; Martino, B.; Gambacorti-Passerini, C.; Abruzzese, E.; Elena, C.; Pregno, P.; Gozzini, A.; Capodanno, I.; Bergamaschi, M.; Crugnola, M.; Bocchia, M.; Galimberti, S.; Rapezzi, D.; Iurlo, A.; Cattaneo, D.; Latagliata, R.; Breccia, M.; Cedrone, M.; Santoro, M.; Annunziata, M.; Levato, L.; Stagno, F.; Cavazzini, F.; Sgherza, N.; Giai, V.; Luciano, L.; Russo, S.; Musto, P.; Caocci, G.; Sorà, F.; Iuliano, F.; Lunghi, F.; Specchia, G.; Pane, F.; Ferrero, D.; Baccarani, M.; Saglio, G.
In: Haematologica, Vol. 104, No. 8, 2019, p. 1589-1596.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice
AU - Fava, C.
AU - Rege-Cambrin, G.
AU - Dogliotti, I.
AU - Cerrano, M.
AU - Berchialla, P.
AU - Dragani, M.
AU - Rosti, G.
AU - Castagnetti, F.
AU - Gugliotta, G.
AU - Martino, B.
AU - Gambacorti-Passerini, C.
AU - Abruzzese, E.
AU - Elena, C.
AU - Pregno, P.
AU - Gozzini, A.
AU - Capodanno, I.
AU - Bergamaschi, M.
AU - Crugnola, M.
AU - Bocchia, M.
AU - Galimberti, S.
AU - Rapezzi, D.
AU - Iurlo, A.
AU - Cattaneo, D.
AU - Latagliata, R.
AU - Breccia, M.
AU - Cedrone, M.
AU - Santoro, M.
AU - Annunziata, M.
AU - Levato, L.
AU - Stagno, F.
AU - Cavazzini, F.
AU - Sgherza, N.
AU - Giai, V.
AU - Luciano, L.
AU - Russo, S.
AU - Musto, P.
AU - Caocci, G.
AU - Sorà, F.
AU - Iuliano, F.
AU - Lunghi, F.
AU - Specchia, G.
AU - Pane, F.
AU - Ferrero, D.
AU - Baccarani, M.
AU - Saglio, G.
N1 - Export Date: 12 November 2019 CODEN: HAEMA Correspondence Address: Fava, C.; Department of Clinical and Biological Sciences, University of TurinItaly; email: carmen.fava@unito.it
PY - 2019
Y1 - 2019
KW - alpha interferon
KW - bosutinib
KW - dasatinib
KW - imatinib
KW - nilotinib
KW - ponatinib
KW - protein tyrosine kinase inhibitor
KW - adult
KW - Article
KW - cancer chemotherapy
KW - cancer patient
KW - chronic myeloid leukemia
KW - chronopharmacology
KW - clinical practice
KW - drug intoxication
KW - drug safety
KW - drug withdrawal
KW - feasibility study
KW - female
KW - follow up
KW - human
KW - Italian (citizen)
KW - leukemia relapse
KW - leukemia remission
KW - major clinical study
KW - male
KW - observational study
KW - oncologist
KW - pregnancy
KW - retreatment
KW - retrospective study
KW - shared decision making
KW - treatment duration
KW - treatment failure
KW - treatment response
KW - treatment withdrawal
U2 - 10.3324/haematol.2018.205054
DO - 10.3324/haematol.2018.205054
M3 - Article
VL - 104
SP - 1589
EP - 1596
JO - Haematologica
JF - Haematologica
SN - 0390-6078
IS - 8
ER -